Monika Vainorius, MD

Monika Vainorius, MD has extensive work experience in the medical and research fields. Monika is currently serving as the Vice President of Clinical Development at CytomX Therapeutics, a position they have held since August 2022. Prior to this, they worked as an Executive Medical Director at the same company from April 2022 to August 2022.

Before joining CytomX Therapeutics, Dr. Vainorius worked at Precision BioSciences, Inc. as a Senior Medical Director from August 2021 to April 2022, and as a Medical Director from March 2020 to August 2021.

From 2017 to 2020, Dr. Vainorius held various positions at the University of North Carolina at Chapel Hill, including Director of Biometrics and Data Quality, Executive Committee member of HCV-TARGET, and Assistant Director of the Data Coordinating Center of HCV-TARGET. Monika also served as a Data Monitoring Manager at HCV-TARGET from 2012 to 2014.

Dr. Vainorius has also worked as a Consultant in Medical Affairs at TARGET PharmaSolutions from June 2016 to January 2018. Before that, they gained experience at Quintiles as an iCRA, where they were involved in the management of study and clinical project team activities across various therapeutic areas.

Earlier in their career, Dr. Vainorius worked as a Clinical Research Associate at PPD from November 2007 to September 2011, where they performed both field and remote monitoring of clinical trials and acted as a lead to clinical study team members.

Monika began their post-doctoral training at Duke University in 2003 and later at the University of Maryland, Baltimore from 2001 to 2003.

Overall, Dr. Monika Vainorius has amassed a wealth of experience in clinical development, medical affairs, data management, and research coordination throughout their career.

Monika Vainorius, MD obtained their High School Diploma from Kaunas Dariaus ir Gireno Gimnazija in 1992. Monika then attended Kaunas Medical University from 1992 to 1999, where they completed their MD degree in Medicine.